HIMS
RLAY icon

Hager Investment Management Services’s Relay Therapeutics RLAY Stock Holding History

Hager Investment Management Services’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8K Hold
2,178
– – 0.02% 156
2026
Q1 		$21.7K Hold
2,178
– – 0.01% 188
2025
Q4 		$18.4K Hold
2,178
– – 0.01% 184
2025
Q3 		$11.4K Buy
+2,178
New +$8.3K 0.01% 207

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Hager Investment Management Services's RLAY Position: Q2 2026 in Review

Hager Investment Management Services held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 2,178 shares worth $40.8K. The position accounts for 0.02% of the portfolio, ranked #156.

Hager Investment Management Services first reported a position in RLAY in Q3 2025 and has held it in 4 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Hager Investment Management Services held 2,178 shares of Relay Therapeutics worth $40.8K as of Q2 2026.
  • Hager Investment Management Services left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up 0.02% of Hager Investment Management Services's portfolio in Q2 2026, its #156 holding.
  • Hager Investment Management Services first reported a position in Relay Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.